|
Contact Us
| |
Bariatric Physicians
2821 S. Parker Road
Ste. 625
Aurora, CO 80014
303.770.2526 | asbp.org
Staff
Laurie Traetow, CAE, CPA
Executive Director
laurie@asbp.org
Beth Amelon
Sponsorships & Exhibits Coordinator
beth@asbp.org
Carly Crosby
Meeting Planner & Executive Coordinator
carly@asbp.org
Marcie Gonzales
Receptionist
marcie@asbp.org
|
|
|
|
Obesity Medicine e-Weekly
|
News
Obesity Medication Alert: LIGHT study stopped
Contrave was approved by the U.S. Food and Drug Administration in September 2014 as an anti-obesity medication in patients who are affected by overweight and obesity and are at a high risk of cardiovascular events. Today, Takeda Pharmaceutical Company Limited and Orexigen Therapeutics, Inc., announced via press release that the LIGHT Cardiovascular Outcomes Trial would be stopped based on a recommendation by the Executive Steering Committee. Read the official press release from Takeda and Orexigen. Read the article about this announcement from Medscape.
 Corporate Advisory Council fosters collaboration among ASBP, OTF, and the corporate community
This year, ASBP and the Obesity Treatment Foundation (OTF) held their inaugural Corporate Advisory Council (CAC) meeting at Obesity Medicine 2015 in Denver. The CAC serves to engage the corporate community and leaders from ASBP and OTF in a collaborative environment to identify areas of common interest and foster partnerships that will advance the field of obesity medicine and improve patient care. During the CAC meeting, ASBP and OTF leaders discussed how partnering with the corporate community will strengthen ASBP and OTF's efforts to advance obesity treatment. These partnerships will help us to: develop a stronger voice with advocacy efforts; raise awareness about the need for obesity medicine education among health care professionals and about the importance of properly treating those affected by obesity; and amplify the quantity and quality of clinical obesity research. ASBP and OTF thank the 2015 Corporate Advisory Council members who are dedicated to advancing the field of obesity medicine with us: Eisai, Inc.; CareCredit; Novo Nordisk, Inc.; Optifast; and Takeda Pharmaceuticals, USA, Inc.
 Printed Obesity Algorithm booklets now available in bundle of five Keep a copy of the Obesity Algorithm in each of your exam rooms to reference during patient visits. Our new bundle of five algorithm booklets is available to order online, and members receive an exclusive bundled price. (You save $45!) Visit the online store to purchase your bundle of five algorithm booklets.
 Apply to join the ASBP Board of Trustees ASBP is now accepting applications for the 2015-2016 Board of Trustees. Interested candidates must complete an application and submit it to ASBP ( email, fax, or mail) by June 5. Available positions include:
- President-elect (two-year term)
- Vice president (one-year term)
- Secretary/treasurer (one-year term)
- Trustee (four positions available, each a two-year term)
|
Foundation
 Abstract submission now open
|
Resources
 The Obesity Treatment Foundation (OTF) helps keep you up to date on current obesity research! Each week, OTF publishes a brief overview of three recent studies so you can be in the know, even during your busiest days. Click the titles below to view the full articles, and please consider supporting OTF so we can continue to provide you with updates on the latest research.
Bandin, C., et al. Int J Obes, 2015.
When a person eats may be just as important as what a person eats. A study was conducted to determine how changes in meal timing (late versus early lunch) affect energy expenditure, glucose tolerance, and circadian-related variables, such as cortisol levels and skin temperature. The study found that delaying the timing of an identical lunch meal for a week resulted in lower resting energy expenditure prior to the meal; decreased fasting carbohydrate oxidation; decreased glucose tolerance; reduced daily variability of free cortisol concentrations, which is associated with obesity; and decreased thermic effect of food. Chronically eating at a later time of day may cause metabolic disturbances and should be considered when counseling patients on their food intake patterns.
Parsons, M. J., et al. Int J Obes, 2015.
Social jetlag is a measure of the discrepancy in sleep timing between work days and free days. Unlike travel-induced jetlag, social jetlag occurs chronically throughout an individual's working life and may have chronic metabolic consequences due to a misaligned circadian system. A study was conducted in 815 non-shift workers to determine how social jetlag relates to obesity-related diseases. The researchers found that individuals with greater social jetlag scores had higher average BMIs, more fat mass, and were more likely to be affected by obesity and meet the criteria for metabolic syndrome. These findings suggest that greater social jetlag increases risk for obesity and metabolic dysfunction.
Fetuin-A: A novel link between obesity and related complications
Trepanowski, J. F.; Mey, J.; and Varady, K. A. Int J Obes, 2015.
Fetuin-A (FetA) is a 64-kDa glycoprotein that is found in relatively high concentrations in human serum and is secreted from the liver and adipose tissue. FetA level is associated with insulin sensitivity, glucose tolerance, lipid levels and both pro- and anti-inflammatory proteins. It has an important role in calcification inhibition, particularly in patients with chronic kidney disease. Diet, aerobic exercise, gastric bypass, metformin, and pioglitazone all reduce circulating levels of FetA, and reductions in FetA are related to improvements in insulin-related variables and adiponectin. FetA may be an important marker in obesity treatment, and this is the first comprehensive review article to describe the specific relationship between FetA and obesity.
|
Education
-
Full Conference
30 CME | Sept. 30-Oct. 4 | RegisterIncludes the Obesity Medicine Certification Review Course and the Fall Obesity Summit.
-
Obesity Medicine Certification Review Course12.5 CME | Sept. 30-Oct. 1 | RegisterProvides preparation to those planning to take the American Board of Obesity Medicine certification exam.
-
Fall Obesity Summit17.5 CME | Oct. 2-4 | RegisterEnhance your knowledge about the latest research and trends in the field of obesity medicine at this summit, with all-new content for the fall.
Refer a provider to an Obesity Basic Medical Treatment course
Another season of Obesity Basic Medical Treatment courses starts next month. This one-day introductory course teaches physicians and health care providers who are brand new to the field of obesity medicine about the basic approaches to obesity treatment. Do you know someone interested in getting involved in obesity medicine? Refer them to a course in their area!
|
|
|
|
|
